Exploring the Future of Cardiovascular Medicine with Dr. Udo Hoffmann, CSO at Cleerly Health

Outcomes Rocket

内容由Saul Marquez提供。所有播客内容（包括剧集、图形和播客描述）均由 Saul Marquez 或其播客平台合作伙伴直接上传和提供。如果您认为有人在未经您许可的情况下使用您的受版权保护的作品，您可以按照此处概述的流程进行操作https://zh.player.fm/legal。

13d ago 11:43

MP3•单集首页

Did you know that patient motivation is enhanced when they can visualize their heart health?

In this episode at ACC.24, Dr. Udo Hoffmann, Chief Scientific Officer at Cleerly Health, shares his passion for pioneering cardiovascular imaging and AI technology at Cleerly. He delves into the importance of addressing coronary artery disease and highlights how Cleerly's groundbreaking AI technology is reducing CT analysis time from hours to minutes, an approach that has earned FDA recognition and is poised to make a significant impact in healthcare. Dr. Hoffman discusses a randomized study comparing risk factor-based care to coronary artery disease-based care, aiming to revolutionize patient management. He also touches on the potential of AI to motivate patients towards proactive healthcare.

Tune in and learn how Cleerly Health is transforming cardiovascular care with cutting-edge AI technology!

Resources:

Watch the entire interview here.
Follow and connect with Udo Hoffmann on LinkedIn.
Learn more about Cleerly on their LinkedIn and website.
Discover more about Cleerly’s prevention trial methods here.
Watch Cleerly’s webinar series about transforming cardiac care here.